Stocks
Enveric Biosciences, Inc.ENVB
NASDAQHealthcareBiotechnology$1.40
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing novel psychedelic-inspired treatments for mental health conditions, including its lead candidate EB-003 for major depressive disorder. Investors track ENVB for its early-stage pipeline and exposure to the growing psychedelics therapeutics space.
52W Range: $1.17-$13.25
Congressional Interest in Enveric Biosciences, Inc. (ENVB)
No congressional trades have been disclosed for Enveric Biosciences, Inc. (ENVB) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading ENVB?
No congressional trades found for this stock.